| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.0086 | 0.9 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.0085 | 0.9 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.0076 | 0.9 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.0078 | 0.9 |